IST, the barometer index, the S&P BSE Sensex, added 218.80 points or 0.29% to 76,949.10. The Nifty 50 index rose 75.55 points or 0.33% to 23,288.75.

Recoveries will need to come from how Indian courts rule on the company's broader insolvency plan and how it aims to repay ...

Bruce Cozadd, the retiring CEO of Jazz Pharmaceuticals, has outlined a developing oncology pipeline at the company. Speaking ...

AbbVie executives said they have high hopes for Skyrizi and Rinvoq in the inflammatory bowel disease market after Humira ...

Goldman Sachs raised the firm’s price target on JPMorgan (JPM) to $295 from $273 and keeps a Buy rating on the shares. The firm cites the ...

JPMorgan Chase & Co.'s Chief Executive Jamie Dimon told analysts on Wednesday he plans to stay in the job "for a few more ...

Fresh off a record year for profit and revenue, JPMorgan is facing questions over what CFO Jeremy Barnum admitted was excess ...

At the JP Morgan Healthcare Conference 2025, Charles River CEO blamed low client spending, loss of a contract and other reasons for lower 2025 projections.

The bank said profit rose 50% to $14 billion in the fourth quarter as noninterest expenses fell 7% from a year earlier.

Zimmer Biomet expressed its optimism that the company will strengthen its market return in 2025 during the JP Morgan ...

U.S. regulators on Wednesday banned the dye called Red 3 from the nation’s food supply, nearly 35 years after it was barred from cosmetics because of potential cancer risk. Food and Drug ...

In a live taping of "The Readout LOUD" at #JPM25, Eli Lilly CEO Dave Ricks talks Trump, Medicare's drug price negotiation, ...